NICOLE STROUP: Open Payments
NPI 1649472358 · LINWOOD, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$375 in 11 payments from 8 companies in 2025. Trend: 2023 $845 · 2024 $449 · 2025 $375
Food & beverage: $300Education: $75
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 1 | $111 |
| Janssen Biotech, Inc. | 2 | $92 |
| Novartis Pharmaceuticals Corporation | 3 | $55 |
| LEO Pharma Inc. | 1 | $33 |
| Incyte Corporation | 1 | $27 |
| UCB, Inc. | 1 | $25 |
| Organon LLC | 1 | $17 |
| Lilly USA, LLC | 1 | $15 |
Products named: DUPIXENT, TREMFYA, COSENTYX, ANZUPGO, OPZELURA, Bimzelx, Rhapsido, VTAMA.
Industry payments across NJ — which companies pay providers there.
